S

Southern Clinical Research Associates | Metairie, LA

Research site

(Unclaimed)

Location

4720 South I-10 Service Road, Suite 200, Metairie, Louisiana, United States of America

Site insights

Top conditions

Top treatments

Vilaprisan

Metronidazole

Telapristone Acetate

Terconazole

Ritonavir

BAY3427080

Elinzanetant

Proellex®

Fezolinetant

PF-07321332

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 27 total trials

A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women Who Have Started Their Periods (SUNFLOWER)

Researchers are looking for a better way to treat women with nonatypical endometrial hyperplasia (NAEH).Endometrial hyperplasia is a condition where...

Begins enrollment in 2 months

Endometrial Hyperplasia

Combination Product: BAY865028

Drug: Medroxyprogesterone acetate

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

This is a Phase 2, prospective, randomized, double-blind, placebo-controlled, multi-center, single-dose, pharmacodynamic study designed to evaluate t...

Enrolling

Interstitial Cystitis

Bladder Pain Syndrome

Drug: Placebo

Drug: Heparin

Study of Plozasiran in Adults With Severe Hypertriglyceridemia (SHASTA-4)

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (...

Enrolling

Severe Hypertriglyceridemia

Drug: Placebo

Drug: Plozasiran Injection

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

The Sponsor is developing a progestin-only contraceptive transdermal system (patch).The main purpose of this study is to look at how safe the study p...

Enrolling

Female Contraception

Drug: Transdermal system containing progestin